GlassScriptPhysician profile
Jennifer A Meyer
NPI 1699891622
$1,882.80
in general payments reported to CMS, 2019-2025
26 companies · $58.78 in 2025
The $58.78 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $197 · 2021: $551 · 2022: $227 · 2023: $286 · 2024: $203 · 2025: $58.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.84 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $486.23 | 2019-2025 | |
| Coopersurgical, INC. | $227.42 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $127.28 | 2019-2023 | Slynd |
| Evofem Biosciences, INC. | $98.06 | 2021-2023 | Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $94.80 | 2019-2023 | |
| Hologic Sales and Service, LLC | $86.18 | 2019-2024 | Thinprep 2000 Processor, Aptima, Third Wave |
| Organon LLC | $83.23 | 2023-2025 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $74.99 | 2021 | |
| Lupin INC. | $62.48 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $61.89 | 2019-2020 | |
| Agile Therapeutics, INC. | $57.52 | 2021-2024 | Twirla |
| Meditrina | $56.05 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $47.99 | 2023-2024 | Myfembree |
| Momentis Surgical INC. | $39.00 | 2022 | |
| Merck Sharp & Dohme LLC | $32.90 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $32.37 | 2021-2022 | |
| Minerva Surgical, INC | $29.58 | 2019-2023 | |
| Vertical Pharmaceuticals, LLC | $29.05 | 2019 | |
| Millicent US INC | $26.70 | 2024 | |
| Covidien LP | $26.56 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $26.15 | 2021 | |
| Mylan Pharmaceuticals INC. | $18.12 | 2021 | |
| Mission Pharmacal Company | $17.46 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.12 | 2019 | |
| Axonics, INC. | $13.12 | 2023 | Axonics |
| Duchesnay USA Incorporated | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.